<DOC>
	<DOC>NCT01652326</DOC>
	<brief_summary>The overarching goal of this project is to improve the clinical quality of patients with Benzodiazepine-resistant alcohol withdrawal syndrome.</brief_summary>
	<brief_title>Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Substance Withdrawal Syndrome</mesh_term>
	<mesh_term>Diazepam</mesh_term>
	<criteria>either 1. a requirement of either 200 mg of diazepam (or diazepam equivalents) in 4 hrs; 2. &gt; 40mg of diazepam (or diazepam equivalents) in 1 hr; or 3. an individual dose of 40 mg or greater of intravenous diazepam for control of agitation if &lt; 18 years of age or had evidence of use of other illicit substances as determined by urine toxicology screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>